Program-aligned supply beyond research scale. As projects progress from milligram screening to gram or kilogram-level requirements, we ensure structural consistency and material continuity.
Focusing on medicinal chemistry building blocks and functionalized scaffolds, our scale-up services support expanded SAR campaigns, toxicology preparation, and preclinical evaluation without the complexity of full-scale manufacturing.
Supporting discovery and preclinical programs that require quantities beyond standard research-scale pack sizes.
15,000+ compounds are available in bulk formats to maintain program momentum during validation studies.
Scale-up continuity is determined by a technical review of the molecular framework and synthetic route.
A technical review is conducted prior to confirmation of scope, batch size, and delivery timeline.
We align material delivery with your program milestones to ensure research and preclinical continuity.
Reserved allocation is ideal for programs requiring repeated access to niche or optimized intermediates.
Material is supplied as research-grade against defined structures and technical specifications.
Documentation requirements should be specified at the time of request for preclinical evaluation alignment.
For programs extending beyond research-scale needs, we coordinate with qualified third-party partners to provide route refinement, process optimization, and extended production models.
